Biofrontera gets Nasdaq extension until May 20, 2024 to regain compliance

Biofrontera Inc.

Nasdaq granted a 180-day extension from Nov 22, 2023 (new deadline May 20, 2024) to regain compliance.
Company had submitted a compliance plan on January 8, 2024, after initial delisting notice.
Must demonstrate compliance with Nasdaq continued listing requirements by the extended deadline.

item 3.01

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-003756

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.